Very Germaine point of questioning on OTHER effects of the administration of Leronlimab in previous trials...I asked several months ago... IF we had information on those that were on Leronlimab continuously with HIV and whether any part of these patients or subset of patients had ANY deleterious effects with COVID-19. DID any of them ...get COVID?. Aside from the privacy issues etc...THAT information would be GOLD.